1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Danone
  6. News
  7. Summary
    BN   FR0000120644

DANONE

(BN)
  Report
Real-time Euronext Paris  -  07:23 2022-06-27 am EDT
52.69 EUR   +0.19%
06/22Global food makers, retailers remain in crisis mode
RE
06/21DANONE : RBC sticks Neutral
MD
06/20DANONE : Gets a Sell rating from Goldman Sachs
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Baby formula crunch in U.S. forces scramble to boost supplies

05/20/2022 | 07:08am EDT
Texas mother struggles to find formula for her baby

(Reuters) - The nationwide shortage of baby formula has prompted the United States to temporarily allow foreign imports from other suppliers, while reaching a deal with Abbott Laboratories on steps to resume production at its Michigan plant.

Top infant formula makers, including Reckitt Benckiser, Nestle and Danone SA, are also ramping up supplies to the country.

Here is a timeline of how the crisis unfolded and measures being taken to resolve it:

Feb. 17

Abbott recalls dozens of types of powdered baby formulas, including Similac, Alimentum and EleCare, made at its Sturgis, Michigan plant after four consumers complained about bacterial infections in infants who had consumed those products; Recalled products had an expiry date of April 1, 2022 or later.

Feb. 21

China's custom officials warn consumers against buying and consuming certain of Abbott's infant and baby products.

Feb. 28

Abbott expands recall to include some Similac PM 60/40 products based on a fifth complaint of a bacterial infection.

March 4

House Appropriations Committee Chairwoman Rosa DeLauro asks for an investigation https://delauro.house.gov/media-center/press-releases/chair-delauro-requests-investigation-fda-handling-abbott-powdered-infant into the FDA's handling of the Abbott recall.

March 9

The Salmonella Newport illness, which was previously included in the investigation of complaints and illnesses, has been removed, the FDA says. The regulator has determined that there is not enough information to definitively link the illness to powdered infant formula.

March 22

FDA probe of Abbott's Michigan facility finds a harmful bacteria called Cronobacter sakazakii on the surface of some areas near infant formula production and reveals Abbott did not have a control system covering all stages of processing to prevent microbe contamination.

April 20

Abbott cuts full-year sales growth forecast, citing the voluntary recall of the infant formula products but keeps profit estimate. Abbott calls the recall a "short-term hindrance".

April 28

House Appropriations Committee Chair Rosa DeLauro in a testimony submits a report acquired from a whistleblower, who had worked at the Abbott facility and had filed a complaint with the FDA in September 2021.

April 29

Abbott says it will release limited quantities of nutrition products that were put on hold after February recall.

May 10

Major U.S. retailers including Target Corp, CVS Health Corp, Walgreens Boots Alliance and Kroger Co place purchase limits on infant formula products.

Abbott says it has been prioritizing production of formula at other plants and ships formula from its Ireland facility.

May 11

U.S. lawmakers plan to hold a hearing on May 25, the House Energy and Commerce Committee says, calling the shortage "increasingly alarming".

Abbott says it could restart production at its Michigan facility within two weeks following approval from the FDA, but add that it would take six to eight weeks for the product to hit the shelves after the resumption.

May 12

President Joe Biden meets with executives from baby formula manufacturers and retailers including Target, Walmart and Nestle's Gerber to address the shortage.

U.S. House Appropriations Committee says FDA Commissioner Robert Califf is set to testify the agency's response to the shortage before the panel on May 19.

May 13

The U.S. House Oversight Committee plans to investigate the shortage, saying it has sent letters seeking information to the four largest manufacturers of baby formula - Abbott Nutrition, Mead Johnson Nutrition, Nestle USA and Perrigo.

U.S. Centers for Disease Control and Prevention (CDC) closes its investigation on Abbott, while Abbott said it has air shipped millions of cans of baby formula powder into the United States from its facility in Ireland.

Store-brand baby formula maker Perrigo Co says shortages and heightened demand may last for the rest of the year.

May 16

The FDA says the United States will allow imports of infant formula from foreign makers that do not usually sell their products in the country.

Abbott reaches agreement with the FDA on the steps needed to resume production at its Michigan plant.

May 17

U.S. House Democrats unveil a bill to provide $28 million in emergency funds to the FDA to help it respond to the shortage and bolster supervision of the industry.

Nestle SA told Reuters it was flying supplies to the country from the Netherlands and Switzerland. Reckitt Benckiser, the second largest U.S. milk formula supplier, is boosting baby formula production by about 30%.

May 18

U.S. President Biden invokes the Defense Production Act to help manufacturers obtain the ingredients needed to ramp up supply.

Several Canadian retailers have imposed purchase limits on baby formula products, says Retail Council of Canada spokesperson, adding the country has not been as hard hit by the shortage.

May 19

Abbott and the FDA are on track to reopen the company's Michigan plant within one or two weeks, FDA Commissioner Robert Califf says.

May 20

French baby formula maker Danone SA has ramped up shipments of infant formula from Europe to the United States, according to U.S. customs data and shipping consultancy Ocean Audit.

(Reporting by Deborah Sophia and Leroy Leo in Bengaluru; Editing by Anil D'Silva and Sriraj Kalluvila)


© Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES 3.05% 109.45 Delayed Quote.-22.23%
CVS HEALTH CORPORATION 2.33% 94.52 Delayed Quote.-8.38%
DANONE 0.15% 52.69 Real-time Quote.-3.66%
KROGER 1.51% 48.45 Delayed Quote.7.05%
NESTLÉ S.A. -0.07% 111.62 Delayed Quote.-12.40%
PERRIGO COMPANY PLC 2.23% 41.21 Delayed Quote.5.94%
RECKITT BENCKISER GROUP PLC -0.10% 6238.72 Delayed Quote.-1.51%
S&P GSCI CLASS III MILK (USD) -2.29% 178.4358 Real-time Quote.13.42%
TARGET CORPORATION 2.46% 150.42 Delayed Quote.-35.01%
WALGREENS BOOTS ALLIANCE, INC. 1.86% 41.65 Delayed Quote.-20.15%
WALMART INC. 0.08% 123.72 Delayed Quote.-14.49%
All news about DANONE
06/22Global food makers, retailers remain in crisis mode
RE
06/21DANONE : RBC sticks Neutral
MD
06/20DANONE : Gets a Sell rating from Goldman Sachs
MD
06/20DANONE : Gets a Buy rating from Barclays
MD
06/20MARKETSCREENER'S WORLD PRESS REVIEW : June 20, 2022
06/20French Food Giant Danone to Cope with Soaring Inflation by Cutting Product Range
MT
06/20Danone trims product range as shoppers balk at high prices
RE
06/17Factbox-Global baby formula makers send products to restock U.S. shelves
RE
06/17DANONE : JP Morgan reiterates its Buy rating
MD
06/17DANONE : Credit Suisse reaffirms its Neutral rating
MD
More news
Analyst Recommendations on DANONE
More recommendations
Financials
Sales 2022 26 267 M 27 708 M 27 708 M
Net income 2022 1 581 M 1 668 M 1 668 M
Net Debt 2022 10 483 M 11 058 M 11 058 M
P/E ratio 2022 19,1x
Yield 2022 3,76%
Capitalization 32 932 M 34 738 M 34 738 M
EV / Sales 2022 1,65x
EV / Sales 2023 1,57x
Nbr of Employees 98 105
Free-Float 88,4%
Chart DANONE
Duration : Period :
Danone Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DANONE
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 52,59 €
Average target price 57,85 €
Spread / Average Target 10,0%
EPS Revisions
Managers and Directors
Antoine Bernard de Saint-Affrique Chief Executive Officer & Director
Juergen Esser Chief Financial, Technology & Data Officer
Gilles Schnepp Non-Executive Chairman
Isabelle Esser Chief Research, Innovation & Food Safety Officer
Vikram Agarwal Chief Operations Officer
Sector and Competitors
1st jan.Capi. (M$)
DANONE-3.66%34 738
NESTLÉ S.A.-12.40%322 709
MONDELEZ INTERNATIONAL, INC.-5.52%86 703
THE KRAFT HEINZ COMPANY6.96%47 003
THE HERSHEY COMPANY14.21%45 430
GENERAL MILLS, INC.4.82%42 534